What Spruce Biosciences, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 19 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 36,636 |
| Disposed | 0 | 10,416 |
| Net activity | +0 | +26,220 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Szwarcberg Javier B. | CHIEF EXECUTIVE OFFICER | Jun 30 | Grant / award · A | +266 | $4.53 | +$1.21K | 19,270 |
| Szwarcberg Javier B. | CHIEF EXECUTIVE OFFICER | Dec 31 | Grant / award · A | +4,690 | $4.53 | +$21.2K | 19,004 |
| Gharib Samir M. | PRESIDENT AND CFO | Dec 15 | Withheld — tax / exercise cost · F | −184 | $80.67 | −$14.8K | 8,263 |
| Gharib Samir M. | PRESIDENT AND CFO | Dec 15 | Exercise / conversion · M | +513 | — | — | 8,447 |
| Gharib Samir M. | PRESIDENT AND CFO | Dec 15 | Withheld — tax / exercise cost · F | −178 | $80.67 | −$14.4K | 7,934 |
| Gharib Samir M. | PRESIDENT AND CFO | Dec 15 | Exercise / conversion · M | +496 | — | — | 8,112 |
| Szwarcberg Javier B. | CHIEF EXECUTIVE OFFICER | Dec 15 | Withheld — tax / exercise cost · F | −608 | $80.67 | −$49K | 14,314 |
| Szwarcberg Javier B. | CHIEF EXECUTIVE OFFICER | Dec 15 | Exercise / conversion · M | +1,196 | — | — | 14,922 |
| Szwarcberg Javier B. | CHIEF EXECUTIVE OFFICER | Dec 15 | Withheld — tax / exercise cost · F | −752 | $80.67 | −$60.7K | 13,726 |
| Szwarcberg Javier B. | CHIEF EXECUTIVE OFFICER | Dec 15 | Exercise / conversion · M | +1,480 | — | — | 14,478 |
| Gharib Samir M. | PRESIDENT AND CFO | Dec 11 | Withheld — tax / exercise cost · F | −680 | $88.41 | −$60.1K | 7,616 |
| Gharib Samir M. | PRESIDENT AND CFO | Dec 11 | Exercise / conversion · M | +1,900 | — | — | 8,296 |
| Ways Kirk | Interim Chief Medical Officer | Dec 11 | Exercise / conversion · M | +1,250 | — | — | 1,250 |
| Szwarcberg Javier B. | CHIEF EXECUTIVE OFFICER | Dec 11 | Withheld — tax / exercise cost · F | −2,194 | $88.41 | −$194K | 12,998 |
| Szwarcberg Javier B. | CHIEF EXECUTIVE OFFICER | Dec 11 | Exercise / conversion · M | +4,950 | — | — | 15,192 |
| Gharib Samir M. | PRESIDENT AND CFO | Dec 10 | Withheld — tax / exercise cost · F | −184 | $85.67 | −$15.8K | 6,396 |
| Gharib Samir M. | PRESIDENT AND CFO | Dec 10 | Exercise / conversion · M | +514 | — | — | 6,580 |
| Szwarcberg Javier B. | CHIEF EXECUTIVE OFFICER | Dec 10 | Withheld — tax / exercise cost · F | −428 | $85.67 | −$36.7K | 10,242 |
| Szwarcberg Javier B. | CHIEF EXECUTIVE OFFICER | Dec 10 | Exercise / conversion · M | +1,196 | — | — | 10,670 |
| Gharib Samir M. | PRESIDENT AND CFO | Oct 20 | Withheld — tax / exercise cost · F | −661 | $148.16 | −$97.9K | 6,066 |
Loading...